hOCT1基因多态性与伊马替尼治疗慢性粒细胞白血病疗效关系的研究
hOCT1기인다태성여이마체니치료만성립세포백혈병료효관계적연구
Influence of hOCT1 polymorphism on imatinib mesylate effectiveness in chronic myelogenous leukemia patients
  • 万方数据
    中华血液学杂志 중화혈액학잡지
    Chinese Journal of Hematology
    2009年 9期 596-600 ,共5页

    胡楠%朱焕玲%刘恒伟%曾春雪%孟文彤%刘霆

    호남%주환령%류항위%증춘설%맹문동%류정

    基因%hOCT1%基因多态性%伊马替尼%白血病%髓样%慢性 基因%hOCT1%基因多態性%伊馬替尼%白血病%髓樣%慢性
    기인%hOCT1%기인다태성%이마체니%백혈병%수양%만성
    Gene%hOCT1%Gene polymorphisms%Imatinib Mesylate%Leukemia%myeloge-nous%chronic
    CT1基因P283L、R287G和M408V位点的多态性与CML患者伊马替尼继发耐药无相关性.
    CT1기인P283L、R287G화M408V위점적다태성여CML환자이마체니계발내약무상관성.
    on between the polymorphisms of hOCT1-P283L, R287G, M408V and secondary IM resistence in CML patients.
    원문보기 원문다운로드 사이트로이동
저자의 최근 논문